Abstract
A serious retroperitoneal bleeding occurred in a 56-year-old male patient receiving unfractionated heparin due to multiple pulmonary embolism. After reducing the heparin dose, the patient developed a new pulmonary embolism and a large thrombus in the right atrium. Concomitantly, the platelet count dropped to a value of 29 g/l. Heparin-induced thrombocytopenia (HIT) was confirmed by a functional assay, the heparin-induced platelet activation (HIPA) assay, whereas the results of a platelet factor 4/heparin complex ELISA were repeatedly negative. This indicated that the patient's HIT antibodies were directed towards an antigen other than platelet factor 4/heparin complexes. For treatment of the atrial thrombus, an ultra-low-dose lysis with rt-PA (2 mg/h, intravenously) was administered for a period of 52 h, overlapping with systemic treatment with recombinant hirudin (Lepirudin, Refludan, 0.06-0.14 mg/kg/h intravenously). The aim was to enhance lysis of the thrombus without increasing the haematoma, and at the same time keep the risk of fulminant pulmonary embolism due to thrombus fragmentation as low as possible. The cardiac thrombus disappeared within 48 h, without new signs of pulmonary embolism. Platelet counts normalized with...Continue Reading
Citations
Dec 12, 2003·The Annals of Thoracic Surgery·Theodore E Warkentin, Andreas Greinacher
Aug 7, 2003·The Annals of Thoracic Surgery·Theodore E Warkentin, Andreas Greinacher
Aug 12, 1999·British Journal of Haematology·G HuhleJ Harenberg
Jan 14, 2004·Kidney International·Katrin Annett PöschelGötz Nowak
Sep 1, 2012·Case Reports in Hematology·Atheer AhmedDavid Campbell
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·N Lubenow, A Greinacher
Dec 22, 2005·American Journal of Hematology·A Davoren, R H Aster
Mar 13, 2002·Chest·Peter S RoseDavid B Pearse
Nov 13, 2001·Reviews in Clinical and Experimental Hematology·A GreinacherV Kiefel
Mar 22, 2000·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·E BuchaH Thieler
Apr 20, 2018·BMJ Case Reports·Sriram GonakotiSudha Vidyasagar
Nov 24, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·N Lubenow, A Greinacher
Jun 8, 2018·Journal of Thrombosis and Thrombolysis·Eiman GhaffarpasandGerald Chi